Metformin Bioequivalence Study [Design Issues]

posted by AB661 – India, 2020-08-19 09:22 (518 d 00:47 ago) – Posting: # 21888
Views: 1,042

Dear Colleagues,

I need your advice please for Metformin Oral Solution. As per Orange book it have AB TE code.
Should BE required to support ANDA application?

Metformin has non-linear pharmacokinetics. There No OGD BE guidance for this product . Whether BE study should be conducted with 500 dose or 1000 mg dose.

I would be grateful if someone could guide me.

With regards
AB

Complete thread:

Activity
 Admin contact
21,831 posts in 4,567 threads, 1,553 registered users;
online 8 (0 registered, 8 guests [including 7 identified bots]).
Forum time: Wednesday 09:10 CET (Europe/Vienna)

Research under a paradigm must be a particularly effective way
of inducing paradigm change.    Thomas S. Kuhn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5